Nippon Express Belgium gains GDP for pharma facility
20 / 01 / 2022
Nippon Express facility at Brussels Airport. Photo: Nippon Express
Freight forwarder Nippon Express Belgium has obtained Good Distribution Practice (GDP) certification for operations at a Medexi-owned pharma facility in Brussels Airport’s cargo area.
The GDP certification is effective December 21 2021 for air and ground forwarding operations, inclusive of inventory control, evidencing Nippon Express Belgium’s compliance with GDP standards for the proper distribution of pharmaceuticals.
A Group company of Japan’s Nippon Express Holdings, Inc., Nippon Express Belgium has signed a business partnership agreement with Medexi, which specialises in pharmaceutical transport, and obtained GDP certification for operations at Medexi’s temperature-controlled 2,000m2 facility dedicated to pharmaceutical products that is capable of both refrigerated (2℃-8℃) and constant-temperature (15℃-25℃) storage.
Medexi’s pharmaceutical knowledge and advanced operational quality will be combined with the Nippon Express Group’s international temperature-controlled transport services and warehouse storage functions to provide customers with a pharmaceutical logistics platform.
Belgium has become a hub for pharmaceutical manufacturing and development, hosting global pharmaceutical companies as well as contract manufacturing organisations, vaccine manufacturers and biotechnology research laboratories.